Taysha Gene Therapies
TSHA
₹231.35
Share price
0.75%
Change (1 day)
20.63%
Change (1 year)
P/S ratio for Taysha Gene Therapies (TSHA)
P/S ratio as of July 2025 (TTM): 96.7
According to Taysha Gene Therapies's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.7. At the end of 2025 the company had a P/S ratio of 54.8.
P/S ratio history for Taysha Gene Therapies from 2020 to 2025
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2025 | 54.8 | 27.25% |
| 2024 | 43.0 | 100.96% |
| 2023 | 21.4 | -62.03% |
| 2022 | 56.4 | |
| 2021 | N/A | |
| 2020 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |